89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ETNB 89Bio, Inc.

停牌 02-06 06:30:15 EST

14.84

+0.00

0.00%

最高14.84	最低14.84	成交量0.00
今开14.84	昨收14.84	日振幅0.00%
总市值22.01亿	流通市值15.39亿	总股本1.48亿
成交额8.25亿	换手率0.00%	流通股本1.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ETNB","market":"US","secType":"STK","nameCN":"89Bio, Inc.","latestPrice":14.84,"timestamp":1761768000000,"preClose":14.84,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":103725128,"shares":148308250,"eps":-3.413952,"marketStatus":"停牌","change":0,"latestTime":"02-06 06:30:15 EST","open":14.84,"high":14.84,"low":14.84,"amount":825457336.525923,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.413952,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770388200000},"marketStatusCode":1,"adr":0,"listingDate":1573448400000,"exchange":"NASDAQ","adjPreClose":14.84,"volumeRatio":0},"requestUrl":"/m/hq/s/ETNB","defaultTab":"news","newsList":[{"id":"1175069785","title":"罗氏收购89Bio, Inc.的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1175069785","media":"投资观察","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175069785?lang=zh_cn&edition=full","pubTime":"2025-10-30 14:18","pubTimestamp":1761805139,"startTime":"0","endTime":"0","summary":"10月30日（瑞士信贷） - 罗氏控股公司：*罗氏在89Bio, Inc.的要约收购中购买股份*罗氏控股公司 - 接受所有89Bio要约中的股份付款*罗氏控股公司 - 每股价格设定为14.50美元，加上最高6.00美元的条件价值权*罗氏控股公司 - 89Bio将成为罗氏的全资子公司*罗氏控股公司 - 约94,113,710股89Bio在要约中被提出*罗氏控股公司 - 今天稍后，罗氏计划通过与蓝鳍合并子公司的合并完成对89Bio的收购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"1165913078","title":"美股开盘 | 三大指数集体高开，英特尔暴涨27%，89bio涨超85%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165913078","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165913078?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:30","pubTimestamp":1758202238,"startTime":"0","endTime":"0","summary":"9月18日，美股三大指数集体高开，纳指涨0.77%，标普500指数涨0.45%，道指涨0.08%。$英特尔$暴涨27%！$英伟达$斥资50亿美元入股英特尔，联手开发PC与数据中心芯片加密货币交易所$Bullish$涨超10%，Q2数字资产销售额达586亿美元$诺和诺德$盘前涨超6%，一项涵盖近6万名糖尿病与心脏病患者的Medicare研究显示，使用Ozempic的患者较使用Trulicity者，心脏病发作、中风或死亡风险降低23%。制药公司$89bio$涨超85%，罗氏将以每股14.50美元收购该公司。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5da189613a1f4746bfcb84c406e7da40","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETNB"],"gpt_icon":0},{"id":"1152518142","title":"89Bio Inc在特定情况下终止与罗氏交易将需支付7990万美元终止费","url":"https://stock-news.laohu8.com/highlight/detail?id=1152518142","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152518142?lang=zh_cn&edition=full","pubTime":"2025-09-18 18:13","pubTimestamp":1758190396,"startTime":"0","endTime":"0","summary":"根据监管文件披露，89Bio Inc表示，如果在特定情况下终止与罗氏的交易，公司将需要支付7990万美元的终止费。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","ETNB","BK4139"],"gpt_icon":0},{"id":"1156039576","title":"盘前异动 | 89bio暴涨89%，Bullish涨超6%；特斯拉、英伟达等科技股普涨，量子计算概念继续狂欢","url":"https://stock-news.laohu8.com/highlight/detail?id=1156039576","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156039576?lang=zh_cn&edition=full","pubTime":"2025-09-18 16:11","pubTimestamp":1758183116,"startTime":"0","endTime":"0","summary":"9月18日，美股三大股指期货上涨，截止发稿，道指期货涨0.47%，纳指期货涨0.78%，标普500指数期货涨0.60%。制药公司89bio盘前涨超89%，罗氏将以每股14.50美元收购该公司。$PayPal$盘前涨近2%，与$谷歌$达成多年合作关系，以革新商业模式。加密货币交易所$Bullish$盘前涨超6%，$Q2$数字资产销售额为586亿美元，去年同期为496亿美元。加密货币概念股盘前普涨， $Figure Technology Solutions$、$Bitmine Immersion Technologies$涨超3%，$Bullish$涨超6%，$Gemini Space Station$、$Circle $、$CleanSpark $涨超2%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/ceff018659a69d5dbc8cb54f5d3600e3","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/ceff018659a69d5dbc8cb54f5d3600e3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4527","BK4533","BK4598","SNX.USD.HKCC","COMP.USD.CC","COMP.USD.HKCC","BK1147","BK4099","LINK.USD.HKCC","LTC.USD.HKCC","DOT.USD.HKCC","BK4587","BK4554","BK4511","BK4567","BK4516","BK4550","BK4543","BK4588","BK4612","DOT.USD.CC","BK4529","JD","BK4608","PDD","ETNB","BK4555","SNX.USD.CC","BK4581","UNI.USD.HKCC","APT.USD.CC","BK4614","BK4551","USDT.USD.CC","BK4534","BK1191","BK4592","BK4548","NVO","UNI.USD.CC","BK4503","LDO.USD.HKCC","TON.USD.HKCC","BK1574","AVAX.USD.HKCC","ATOM.USD.HKCC","NVDA","BK4574","BK4594","BK4579","MKR.USD.CC","BK4601","BK4604","TON.USD.CC","BK4532","DYDX.USD.HKCC","TSLA","BK4141","BABA","AVAX.USD.CC","BK4585","BK4605","APT.USD.HKCC","BK4549","AAPL"],"gpt_icon":1},{"id":"2568756421","title":"罗氏(RHHBY.US)将以高达35亿美元收购89bio(ETNB.US) 加码减肥药市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2568756421","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568756421?lang=zh_cn&edition=full","pubTime":"2025-09-18 15:28","pubTimestamp":1758180528,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，罗氏将以高达35亿美元的价格收购生物制药公司89bio，这是该瑞士制药商进军减肥药及相关疗法市场的最新举措。罗氏将以每股14.50美元的现金收购89bio，股权总价值约为24亿美元。罗氏计划加快其实验性减肥药物的研发进程，这些药物在较小规模的试验中取得的数据好坏参半，但目前正朝着临床开发的关键最后阶段迈进。罗氏近期最大的几笔交易都与肥胖症相关。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","03165","BK4585","ETNB","RHHBY","BK4007"],"gpt_icon":0},{"id":"1133010171","title":"罗氏集团宣布将以每股14.5美元收购生物制药公司89bio","url":"https://stock-news.laohu8.com/highlight/detail?id=1133010171","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133010171?lang=zh_cn&edition=full","pubTime":"2025-09-18 13:45","pubTimestamp":1758174349,"startTime":"0","endTime":"0","summary":"生物制药公司89bio涨超18%，罗氏集团今日宣布将以每股14.50美元收购该公司。消息方面：罗氏集团今日宣布签署最终并购协议，将全面收购89bio公司。根据并购协议，罗氏将立即启动要约收购，以每股14.50美元现金收购89bio全部流通普通股，同时授予不可交易 contingent value right——在达成特定里程碑时最高可额外获得每股6.00美元现金。89bio将提交推荐声明，其董事会一致建议股东接受要约收购。完成要约收购后，罗氏将通过第二步合并以相同对价收购剩余股份。","market":"us","thumbnail":"https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"720d08cdcd6a785ff31d49645aa5188d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETNB"],"gpt_icon":0},{"id":"2559676634","title":"89Bio, Inc.盘中异动 急速上涨5.02%报9.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559676634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559676634?lang=zh_cn&edition=full","pubTime":"2025-08-13 03:24","pubTimestamp":1755026683,"startTime":"0","endTime":"0","summary":"北京时间2025年08月13日03时24分，89Bio, Inc.股票出现异动，股价急速拉升5.02%。截至发稿，该股报9.21美元/股，成交量66.6124万股，换手率0.45%，振幅5.53%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508130324439743adb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508130324439743adb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2558698346","title":"89Bio, Inc.盘中异动 快速跳水5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558698346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558698346?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:45","pubTimestamp":1754919936,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时45分，89Bio, Inc.股票出现异动，股价急速跳水5.84%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Entero Therapeutics Inc.、Equillium, Inc.、Puma Biotechnology Inc涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃，换手率分别为2750.99%、261.91%、82.65%，振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.，振幅分别为74.27%、69.75%、20.72%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121453694dcc4dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081121453694dcc4dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ETNB","BK4585"],"gpt_icon":0},{"id":"1172959417","title":"异动解读 | 89Bio股价盘中大跌5.65%，季度业绩不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1172959417","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172959417?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:44","pubTimestamp":1754660693,"startTime":"0","endTime":"0","summary":"生物制药公司89Bio, Inc.今日盘中股价大跌5.65%，引发投资者关注。这一显著跌幅主要源于公司最新发布的季度财报未能达到分析师预期。根据89Bio公布的财报，截至6月30日的季度调整后每股亏损为71美分，远低于分析师平均预期的49美分亏损。这一业绩表现明显低于市场预期，导致投资者信心受挫。值得注意的是，89Bio今年以来的股价表现仍相对强劲，截至上一季度累计上涨21.2%。这表明尽管短期面临挑战，市场对89Bio的长期发展仍持相对乐观态度。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ETNB"],"gpt_icon":0},{"id":"1170327667","title":"异动解读 | 89Bio盘中大跌5.65%，季度亏损超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1170327667","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170327667?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:39","pubTimestamp":1754660364,"startTime":"0","endTime":"0","summary":"生物制药公司89Bio, Inc.今日盘中大跌5.65%，投资者对公司最新公布的季度业绩表示失望。根据公司公告，89Bio截至6月30日的季度调整后每股亏损为0.71美元，大幅超过分析师平均预期的0.49美元亏损。这已经是公司连续第四个季度未能达到盈利预期。尽管89Bio的股价今日遭遇重挫，但值得注意的是，该公司股票今年以来仍上涨了21.2%。投资者将密切关注89Bio未来的业绩表现，以评估公司能否扭转局面，实现盈利预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ETNB"],"gpt_icon":0},{"id":"2557530832","title":"89Bio, Inc.盘中异动 股价大涨5.16%报10.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557530832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557530832?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:52","pubTimestamp":1754488331,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时52分，89Bio, Inc.股票出现波动，股价快速上涨5.16%。截至发稿，该股报10.19美元/股，成交量18.0454万股，换手率0.12%，振幅5.78%。89Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806215211a478e13f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806215211a478e13f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2518703262","title":"89Bio, Inc.盘中异动 股价大跌5.10%报7.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518703262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518703262?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:47","pubTimestamp":1741614433,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时47分，89Bio, Inc.股票出现波动，股价快速跳水5.10%。截至发稿，该股报7.45美元/股，成交量9.118万股，换手率0.06%，振幅3.95%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214713abf30247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214713abf30247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2518440673","title":"89Bio, Inc.2024财年实现净利润-3.67亿美元，同比减少158.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518440673","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518440673?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449623,"startTime":"0","endTime":"0","summary":"3月9日，89Bio, Inc.公布财报，公告显示公司2024财年净利润为-3.67亿美元，同比减少158.45%；其中营业收入为0.00美元，每股基本收益为-3.51美元。从资产负债表来看，89Bio, Inc.总负债77.90百万美元，其中短期债务727000.00美元，资产负债比为0.07，流动比率为0.14。机构评级：截至2025年3月9日，当前有9家机构对89Bio, Inc.目标价做出预测，其中目标均价为29.67美元，其中最低目标价为12.00美元，最高目标价为51.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000038abef9700&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000038abef9700&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB"],"gpt_icon":0},{"id":"2516311371","title":"HC Wainwright & Co.：重申89bio(ETNB.US)评级，由买入调整至买入评级, 目标价由29.00美元调整至21.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516311371","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516311371?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:21","pubTimestamp":1740759694,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申89bio(ETNB.US)评级，由买入调整至买入评级, 目标价由29.00美元调整至21.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01002148469142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ETNB"],"gpt_icon":0},{"id":"2514354518","title":"89bio(ETNB.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-1.02美元，前值为-0.50美元，预期值为-0.73美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354518","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514354518?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:08","pubTimestamp":1740697717,"startTime":"0","endTime":"0","summary":"89bio(ETNB.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-1.02美元，前值为-0.50美元，预期值为-0.73美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28070848442545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ETNB"],"gpt_icon":0},{"id":"1145283862","title":"89bio 2024年第四季度GAAP每股收益$(1.02)，低于$(0.77)的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1145283862","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145283862?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:46","pubTimestamp":1740692807,"startTime":"0","endTime":"0","summary":"89bio  报告的季度亏损为每股$，低于分析师共识预期的$，低32.47%。与去年同期每股亏损$相比，减少了104%。以上内容来自Benzinga Earnings专栏，原文如下：89bio  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 32.47 percent. This is a 104 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"89bio 2024年第四季度GAAP每股收益$(1.02)，低于$(0.77)的预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETNB"],"gpt_icon":0},{"id":"2514389295","title":"89Bio, Inc.盘中异动 大幅上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514389295?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:13","pubTimestamp":1740669233,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时13分，89Bio, Inc.股票出现异动，股价急速拉升5.21%。截至发稿，该股报9.69美元/股，成交量23.3454万股，换手率0.16%，振幅5.81%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231353a256852e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227231353a256852e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ETNB","BK4139"],"gpt_icon":0},{"id":"2514801307","title":"89Bio, Inc.盘中异动 早盘股价大跌5.03%报9.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514801307?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:22","pubTimestamp":1740496952,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时22分，89Bio, Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报9.62美元/股，成交量30.4897万股，换手率0.21%，振幅4.77%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232232abdc8b43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232232abdc8b43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ETNB","BK4585"],"gpt_icon":0},{"id":"2513384720","title":"89Bio, Inc.盘中异动 早盘大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513384720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513384720?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:03","pubTimestamp":1740409380,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时03分，89Bio, Inc.股票出现波动，股价快速跳水5.06%。截至发稿，该股报10.50美元/股，成交量11.5698万股，换手率0.08%，振幅5.47%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230300962ea0b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230300962ea0b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2509280422","title":"89Bio, Inc.盘中异动 股价大涨5.40%报11.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509280422?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:15","pubTimestamp":1738768527,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时15分，89Bio, Inc.股票出现波动，股价大幅上涨5.40%。截至发稿，该股报11.33美元/股，成交量46.3866万股，换手率0.32%，振幅5.35%。89Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。89Bio, Inc.公司简介：89bio Inc 是一家总部位于美国的临床阶段生物制药公司，专注于肝脏和心脏代谢疾病疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231528987b8407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231528987b8407&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.89bio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.6192},{"period":"1year","weight":0.2727},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0237},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.0099},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1215},{"period":"ytd","weight":-0.0063}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"89bio, Inc.于2019年6月作为一家特拉华州公司成立，以经营2018年1月在以色列注册成立的89Bio有限公司的业务。该公司是一家临床阶段的生物制药公司，专注于治疗肝脏和心脏代谢疾病的创新疗法的开发和商业化。公司主导候选产品pegozafermin是一种专门设计的成纤维细胞生长因子的糖聚乙二醇化类似物，目前正在开发用于治疗非酒精性脂肪性肝炎和用于治疗严重的高甘油三酯血症。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.111427},{"month":2,"riseRate":0.666667,"avgChangeRate":0.102838},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.098837},{"month":4,"riseRate":0.5,"avgChangeRate":-0.083264},{"month":5,"riseRate":0.666667,"avgChangeRate":0.08296},{"month":6,"riseRate":0.5,"avgChangeRate":-0.019291},{"month":7,"riseRate":0.5,"avgChangeRate":0.06852},{"month":8,"riseRate":0.833333,"avgChangeRate":0.129221},{"month":9,"riseRate":0.5,"avgChangeRate":0.05512},{"month":10,"riseRate":0.5,"avgChangeRate":-0.001577},{"month":11,"riseRate":0.6,"avgChangeRate":-0.000698},{"month":12,"riseRate":0.333333,"avgChangeRate":0.097135}],"exchange":"NASDAQ","name":"89Bio, Inc.","nameEN":"89Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"89Bio, Inc.,ETNB,89Bio, Inc.股票,89Bio, Inc.股票老虎,89Bio, Inc.股票老虎国际,89Bio, Inc.行情,89Bio, Inc.股票行情,89Bio, Inc.股价,89Bio, Inc.股市,89Bio, Inc.股票价格,89Bio, Inc.股票交易,89Bio, Inc.股票购买,89Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"89Bio, Inc.(ETNB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供89Bio, Inc.(ETNB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}